Topotarget Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108M

Topotarget General Information

Description

Producer of biopharmaceutical products. The company engages in clinical development and registration of oncology products. It primarily develops drugs for the treatment of hematological malignancies, solid tumors and cancer therapies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 39
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 39

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Topotarget Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 05-Aug-2014 $108M Completed Profitable
2. Early Stage VC 27-Jun-2007 Completed Startup
1. Early Stage VC 01-Dec-2006 $24.4M $24.4M Completed Startup
To view Topotarget’s complete valuation and funding history, request access »

Topotarget Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares 156,116 $3.03 $3.03 1x $3.03 0.25%
Ordinary Shares 577,700 $1.5 $1.5 1x $1.5 0.94%
To view Topotarget’s complete cap table history, request access »

Topotarget Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Topotarget Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Banexi Ventures Partners Venture Capital Minority
HealthCap Venture Capital Minority
To view Topotarget’s complete investors history, request access »

Topotarget Acquisitions (2)

Topotarget’s most recent deal was a Merger/Acquisition with Apoxis for . The deal was made on 27-Jun-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Apoxis 27-Jun-2007 Merger/Acquisition Drug Discovery
Prolifix 04-Jun-2002 Merger/Acquisition Drug Discovery
To view Topotarget’s complete acquisitions history, request access »

Topotarget FAQs

  • When was Topotarget founded?

    Topotarget was founded in 2000.

  • Where is Topotarget headquartered?

    Topotarget is headquartered in Copenhagen, Denmark.

  • What is the size of Topotarget?

    Topotarget has 13 total employees.

  • What industry is Topotarget in?

    Topotarget’s primary industry is Drug Discovery.

  • Is Topotarget a private or public company?

    Topotarget is a Private company.

  • What is the current valuation of Topotarget?

    The current valuation of Topotarget is .

  • What is Topotarget’s current revenue?

    The current revenue for Topotarget is .

  • How much funding has Topotarget raised over time?

    Topotarget has raised $109M.

  • Who are Topotarget’s investors?

    Banexi Ventures Partners and HealthCap have invested in Topotarget.

  • When was Topotarget acquired?

    Topotarget was acquired on 05-Aug-2014.

  • Who acquired Topotarget?

    Topotarget was acquired by Valerio Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process